mafosfamide has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabretta, B; Malaguarnera, L; Nieborowska-Skórska, M; Ratajczak, MZ; Skórski, T; Szczylik, C | 1 |
Almici, C; Caramatti, C; Carlo-Stella, C; Garau, D; Mangoni, L; Piovani, G; Rizzoli, V | 1 |
2 other study(ies) available for mafosfamide and Granulocytic Leukemia, Chronic, Stable Phase
Article | Year |
---|---|
Successful mafosfamide purging of bone marrow from chronic myelogenous leukemia (CML) cells.
Topics: Antineoplastic Agents; Blast Crisis; Bone Marrow; Bone Marrow Purging; Colony-Forming Units Assay; Cyclophosphamide; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid, Chronic-Phase; Oligonucleotide Probes; Polymerase Chain Reaction; Tumor Cells, Cultured | 1993 |
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Evaluation Studies as Topic; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Chronic-Phase; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged | 1991 |